LAM
VKTX icon

Lewis Asset Management’s Viking Therapeutics VKTX Stock Holding History

Lewis Asset Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Buy
66,790
+2,700
+4% +$87.2K 0.91% 29
2026
Q1 		$2.09M Buy
64,090
+2,200
+4% +$70.7K 0.85% 30
2025
Q4 		$2.18M Buy
61,890
+5,960
+11% +$211K 0.89% 28
2025
Q3 		$1.47M Buy
55,930
+11,870
+27% +$354K 0.6% 40
2025
Q2 		$1.17M Buy
44,060
+385
+0.9% +$10.1K 0.55% 45
2025
Q1 		$1.05M Buy
43,675
+2,400
+6% +$75.9K 0.87% 26
2024
Q4 		$1.66M Buy
41,275
+10,880
+36% +$620K 1.27% 19
2024
Q3 		$1.92M Buy
30,395
+3,950
+15% +$232K 1.4% 15
2024
Q2 		$1.4M Buy
26,445
+10,320
+64% +$676K 1.07% 19
2024
Q1 		$1.32M Buy
+16,125
New +$717K 1.09% 18

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Lewis Asset Management's VKTX Position: Q2 2026 in Review

Lewis Asset Management increased its Viking Therapeutics (VKTX) stake by 4.2% in Q2 2026, buying an estimated $87.2K and bringing the position to 66,790 shares worth $2.61M. The position accounts for 0.91% of the portfolio, ranked #29.

Lewis Asset Management first reported a position in VKTX in Q1 2024 and has held it in 10 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Lewis Asset Management held 66,790 shares of Viking Therapeutics worth $2.61M as of Q2 2026.
  • Lewis Asset Management bought 2,700 Viking Therapeutics shares in Q2 2026, an estimated $87.2K.
  • Viking Therapeutics made up 0.91% of Lewis Asset Management's portfolio in Q2 2026, its #29 holding.
  • Lewis Asset Management first reported a position in Viking Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Lewis Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.